Thomas Van Speybroeck

Supervisor Laboratory Operations at Orionis Biosciences

Thomas Van Speybroeck has a diverse work experience in the field of biosciences. Thomas started their career in 2011 as an apprentice at KU Leuven, where they worked in the Laboratory of Biosignaling & Therapeutics under the supervision of Dr. Silvia Jansen. In this role, they gained valuable experience and developed skills in the field of life sciences.

After completing their internship, Thomas joined UGent - VIB in 2011 as a Laboratory Technician in the Cytokine Receptor Lab. Here, they played a crucial role in drug discovery projects and contributed to the development of a drug discovery platform for small molecule protein-protein interaction modulators.

In 2016, Thomas joined Orionis Biosciences as a Senior Research Associate. In this position, they specialized in the development of new drugs for autoimmune diseases and cancer. Apart from their research responsibilities, they also managed the laboratory, handled purchases and logistics, and maintained contact with sales representatives and service providers.

Overall, Thomas has demonstrated their expertise and dedication to the field of biosciences through their various roles and achievements in these organizations.

Thomas Van Speybroeck earned their Bachelor's degree in Biochemistry from AP Hogeschool Antwerpen, which they attended from 2007 to 2011. In 2020, they enrolled in the European Academy for Natural Healthcare, where they pursued studies in Foods, Nutrition, and Wellness Studies, General, although they did not complete a degree. In 2021, Thomas attended Prebes - Well-being at work, focusing on Occupational Safety and Health Technology/Technician. In 2022, they studied Foods, Nutrition, and Wellness Studies, General at the Evening Education Center.

Location

Ghent, Belgium

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Orionis Biosciences

1 followers

Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.


Employees

11-50

Links